Table 2.
AMO positive | AMO negative | P | |
---|---|---|---|
n = 122 | n = 430 | ||
Age (years)
Median (IQR) (min/max) |
34 (24,2)(13 - 95) | 39 (27) (13 - 95) | 0,07 |
Gender (n/%) Female | 53 (43,4%) | 225 (52,3%) | |
Male | 69 (56,5%) | 205 (47,6%) | 0,344 |
30 (24,5%) | 58 (13,4%) | *0,003 | |
56 (45,9%) | 154 (35,8%) | *0,046 | |
Primary ostium obstruction(n/%) | |||
27 (22,1%) | 58 (13,4%) | *0,019 | |
Mucous retention cyst(n/%) | |||
18 (14,7%) | 43 (10,0%) | 0,13 | |
Agger nasi cell(n/%) | |||
6 (4,9%) | 13 (3,02%) | 0,308 | |
Haller cell(n/%) | |||
3 (2,4%) | 18 (4,1%) | 0,38 | |
Septum deviation(n/%) | |||
54 (44,2%) | 212 (49,3%) | 0,33 | |
MS hypoplasia(n/%) | |||
5 (4,09%) | 34 (7,9%) | 0,14 | |
Paradox concha(n/%) | |||
15 (12,2%) | 34 (7,9%) | 0,13 | |
Atelectatic uncinate process(n/%) | 4 (4,09%) | 10 (2,3%) | 0,55 |
34 (27,8%) | 103 (23,9%) | 0,36 | |
8 (6,5%) | 29 (6,7%) | 0,94 | |
AMO; Accessory maxillary ostium, n; number of sinuses. Max; maximum, Min; minimum, MS; maxillary sinus, IQR; interquartile range, *; significant.